Decreased copy number of mitochondrial DNA: A potential diagnostic criterion for gastric cancer

Wen,Shi‑Lei; Zhang,Feng; Feng,Shi

doi:10.3892/ol.2013.1492

Decreased copy number of mitochondrial DNA: A potential diagnostic criterion for gastric cancer

Authors:
- Shi‑Lei Wen
- Feng Zhang
- Shi Feng
View Affiliations

Affiliations: Department of Human Anatomy, Academy of Preclinical and Forensic Medicine, West China Medicine College, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of Thoracic and Cardiovascular Surgery, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, P.R. China
Published online on: July 25, 2013 https://doi.org/10.3892/ol.2013.1492
Pages: 1098-1102

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An alteration in the mitochondrial DNA (mtDNA) copy number has been detected in numerous human cancers. However, certain changes in the mtDNA copy number that occur during the initiation and progression of gastric cancer remain undetected. In the present study, using quantitative PCR analysis, the quantitative changes in mtDNA were observed during the initiation and progression of gastric cancer. Furthermore, the possible correlation between the changes in mtDNA and the clinicopathological stage were also investigated. However, the mechanism by which the change in mtDNA copy number occurs remains to be elucidated. Epigenetic changes are believed to play a significant role in regulating the mtDNA content. In order to determine whether there is a potential correlation between DNA methylation and mtDNA regulation, in vitro demethylation experiments were performed. Tumor tissues and corresponding non‑cancerous tissues were surgically resected from 76 gastric cancer patients between 2010 and 2011. The results revealed that the average relative mtDNA copy numbers were 94.71±28.11 in the cancer tissues and 111.68±21.84 in the corresponding non‑cancerous tissues (P<0.01). The quantitative changes in mtDNA demonstrated a significant decrease in gastric cancer, particularly in ill‑defined stage III and IV cases, but had no association with gender. The mtDNA copy numbers demonstrated a marked increase (P<0.05) following demethylation treatment. The present results indicate that the mtDNA copy number plays a significant role during the progression of colorectal cancer, particularly during the late clinicopathological stages, and that the change in the mtDNA copy number may correlate with DNA methylation.

View Figures

View References

1	Thun MJ, DeLancey JO, Center MM, Jemal A and Ward EM: The global burden of cancer: priorities for prevention. Carcinogenesis. 31:100–110. 2010. View Article : Google Scholar : PubMed/NCBI
2	Chen WQ, Zheng RS, Zhang SW, Li N, Zhao P, Li GL, Wu LY and He J: Report of incidence and mortality in china cancer registries, 2008. Chin J Cancer Res. 24:171–180. 2012. View Article : Google Scholar : PubMed/NCBI
3	Liu J and Chen L: Current status and progress in gastric cancer with liver metastasis. Chin Med J (Engl). 124:445–456. 2011.PubMed/NCBI
4	Anderson S, Bankier AT, Barrell BG, et al: Sequence and organization of the human mitochondrial genome. Nature. 290:457–465. 1981. View Article : Google Scholar : PubMed/NCBI
5	Taanman JW: The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta. 1410:103–123. 1999. View Article : Google Scholar : PubMed/NCBI
6	Lightowlers RN, Chinnery PF, Turnbull DM and Howell N: Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet. 13:450–455. 1997. View Article : Google Scholar : PubMed/NCBI
7	Barrientos A, Casademont J, Cardellach F, Estivill X, Urbano-Marquez A and Nunes V: Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Brain Res Mol Brain Res. 52:284–289. 1997. View Article : Google Scholar : PubMed/NCBI
8	Yu M: Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers. Life Sci. 89:65–71. 2011. View Article : Google Scholar : PubMed/NCBI
9	Honda K, Kato K, Dairaku N, et al: High levels of intracellular ATP prevent nitric oxide-induced apoptosis in rat gastric mucosal cells. Int J Exp Pathol. 84:281–288. 2003. View Article : Google Scholar : PubMed/NCBI
10	Parr RL, Dakubo GD, Thayer RE, McKenney K and Birch-Machin MA: Mitochondrial DNA as a potential tool for early cancer detection. Hum Genomics. 2:252–257. 2006. View Article : Google Scholar : PubMed/NCBI
11	Lee HC, Yin PH, Lin JC, et al: Mitochondrial genome instability and mtDNA depletion in human cancers. Ann NY Acad Sci. 1042:109–122. 2005. View Article : Google Scholar : PubMed/NCBI
12	Egan K, Kusao I, Troelstrup D, Agsalda M and Shiramizu B: Mitochondrial DNA in residual leukemia cells in cerebrospinal fluid in children with acute lymphoblastic leukemia. J Clin Med Res. 2:225–229. 2010.PubMed/NCBI
13	Chen T, He J, Shen L, et al: The mitochondrial DNA 4,977-bp deletion and its implication in copy number alteration in colorectal cancer. BMC Med Genet. 12:82011. View Article : Google Scholar : PubMed/NCBI
14	Feng S, Xiong L, Ji Z, Cheng W and Yang H: Correlation between increased copy number of mitochondrial DNA and clinicopathological stage in colorectal cancer. Oncol Lett. 2:899–903. 2011.PubMed/NCBI
15	Lin CS, Chang SC, Wang LS, et al: The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J Thorac Cardiovasc Surg. 139:189–197. 2010. View Article : Google Scholar : PubMed/NCBI
16	Kusao I, Agsalda M, Troelstrup D, Villanueva N and Shiramizu B: Chemotoxicity recovery of mitochondria in non-Hodgkin lymphoma resulting in minimal residual disease. Pediatr Blood Cancer. 51:193–197. 2008. View Article : Google Scholar : PubMed/NCBI
17	Mambo E, Chatterjee A, Xing M, et al: Tumor-specific changes in mtDNA content in human cancer. Int J Cancer. 116:920–924. 2005. View Article : Google Scholar : PubMed/NCBI
18	Mizumachi T, Muskhelishvili L, Naito A, et al: Increased distributional variance of mitochondrial DNA content associated with prostate cancer cells as compared with normal prostate cells. Prostate. 68:408–417. 2008. View Article : Google Scholar : PubMed/NCBI
19	Fan AX, Radpour R, Haghighi MM, et al: Mitochondrial DNA content in paired normal and cancerous breast tissue samples from patients with breast cancer. J Cancer Res Clin Oncol. 135:983–989. 2009. View Article : Google Scholar : PubMed/NCBI
20	Vivekanandan P, Daniel H, Yeh MM and Torbenson M: Mitochondrial mutations in hepatocellular carcinomas and fibrolamellar carcinomas. Mod Pathol. 23:790–798. 2010. View Article : Google Scholar : PubMed/NCBI
21	Yu M, Wan Y and Zou Q: Decreased copy number of mitochondrial DNA in Ewing’s sarcoma. Clin Chim Acta. 411:679–683. 2010.PubMed/NCBI
22	Lin CS, Wang LS, Tsai CM and Wei YH: Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg. 7:954–958. 2008. View Article : Google Scholar : PubMed/NCBI
23	Meierhofer D, Mayr JA, Foetschl U, et al: Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis. 25:1005–1010. 2004. View Article : Google Scholar : PubMed/NCBI
24	Qu F, Liu X, Zhou F, et al: Association between mitochondrial DNA content in leukocytes and colorectal cancer risk: a case-control analysis. Cancer. 117:3148–3155. 2011. View Article : Google Scholar : PubMed/NCBI
25	Shen J, Platek M, Mahasneh A, Ambrosone CB and Zhao H: Mitochondrial copy number and risk of breast cancer: a pilot study. Mitochondrion. 10:62–68. 2010. View Article : Google Scholar : PubMed/NCBI
26	Bonner MR, Shen M, Liu CS, Divita M, He X and Lan Q: Mitochondrial DNA content and lung cancer risk in Xuan Wei, China. Lung Cancer. 63:331–334. 2009. View Article : Google Scholar : PubMed/NCBI
27	Chinnery PF, Elliott HR, Hudson G, Samuels DC and Relton CL: Epigenetics, epidemiology and mitochondrial DNA diseases. Int J Epidemiol. 41:177–187. 2012. View Article : Google Scholar : PubMed/NCBI
28	Feng S, Xiong L, Ji Z, Cheng W and Yang H: Correlation between increased ND2 expression and demethylated displacement loop of mtDNA in colorectal cancer. Mol Med Rep. 6:125–130. 2012.PubMed/NCBI
29	Hamilton SR and Aaltonen LA: World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System. IARC Press; Lyon, France: 2000
30	Tanigawa N, Amaya H, Matsumura M, Lu C and Iki M: Association between tumor angiogenesis and Borrmann type 4 carcinomas of the stomach. Oncology. 55:461–467. 1998. View Article : Google Scholar : PubMed/NCBI
31	Park SY, Shin MG, Kim HR, et al: Alteration of mitochondrial DNA sequence and copy number in nasal polyp tissue. Mitochondrion. 9:318–325. 2009. View Article : Google Scholar : PubMed/NCBI
32	Warburg O: On the origin of cancer cells. Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
33	Kim MM, Clinger JD, Masayesva BG, et al: Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin Cancer Res. 10:8512–8515. 2004. View Article : Google Scholar : PubMed/NCBI